Phase-two clinical trials of Covaxin for Covid-19 to begin from Aug 10
Phase-two clinical trials of Covaxin for Covid-19 to begin from Aug 10 COVAXIN, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) high containment …
Phase-two clinical trials of Covaxin for Covid-19 to begin from Aug 10 Read More »
